Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 579

1.

An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency.

Shen C, Zhang M, Chen Y, Zhang L, Wang G, Chen J, Chen S, Li Z, Wei F, Chen J, Yang K, Guo S, Wang Y, Zheng Q, Yu H, Luo W, Zhang J, Chen H, Chen Y, Xia N.

Theranostics. 2019 Jan 1;9(1):210-231. doi: 10.7150/thno.28434. eCollection 2019.

PMID:
30662563
2.

Influenza B virus infection complicated by life-threatening pericarditis: a unique case-report and literature review.

Spoto S, Valeriani E, Locorriere L, Anguissola GB, Pantano AL, Terracciani F, Riva E, Ciccozzi M, Costantino S, Angeletti S.

BMC Infect Dis. 2019 Jan 10;19(1):40. doi: 10.1186/s12879-018-3606-7.

3.

Evaluation of Influenza A H1N1 infection and antiviral utilization in a tertiary care hospital.

Belucci TR, Marra AR, Edmond MB, Pinho JRR, Yokota PKO, Mafra ACCN, Dos Santos OFP.

BMC Infect Dis. 2018 Nov 16;18(1):579. doi: 10.1186/s12879-018-3492-z.

4.

Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study.

Leneva IA, Falynskova IN, Makhmudova NR, Poromov AA, Yatsyshina SB, Maleev VV.

J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25358. [Epub ahead of print]

PMID:
30431664
5.

Respiratory viruses in returning Hajj & Umrah pilgrims with acute respiratory illness in 2014-2015.

Koul PA, Mir H, Saha S, Chadha MS, Potdar V, Widdowson MA, Lal RB, Krishnan A.

Indian J Med Res. 2018 Sep;148(3):329-333. doi: 10.4103/ijmr.IJMR_890_17.

6.

Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration.

Jia X, Liu B, Bao L, Lv Q, Li F, Li H, An Y, Zhang X, Cao B, Wang C.

PLoS Pathog. 2018 Nov 13;14(11):e1007428. doi: 10.1371/journal.ppat.1007428. eCollection 2018 Nov.

7.

Oseltamivir in pregnancy and birth outcomes.

Ehrenstein V, Kristensen NR, Monz BU, Clinch B, Kenwright A, Sørensen HT.

BMC Infect Dis. 2018 Oct 16;18(1):519. doi: 10.1186/s12879-018-3423-z.

8.

Using a novel rapid viral test to improve triage of emergency department patients with acute respiratory illness during flu season.

Pedersen CJ, Rogan DT, Yang S, Quinn JV.

J Clin Virol. 2018 Nov;108:72-76. doi: 10.1016/j.jcv.2018.09.008. Epub 2018 Sep 15.

PMID:
30261422
9.

Takotsubo cardiomyopathy triggered by influenza B.

Elikowski W, Małek-Elikowska M, Lisiecka M, Trypuć Z, Mozer-Lisewska I.

Pol Merkur Lekarski. 2018 Aug 29;45(266):67-70.

PMID:
30240371
10.

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A; Baloxavir Marboxil Investigators Group.

N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197.

11.

Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza.

Ali SO, Takas T, Nyborg A, Shoemaker K, Kallewaard NL, Chiong R, Dubovsky F, Mallory RM.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00694-18. doi: 10.1128/AAC.00694-18. Print 2018 Nov.

PMID:
30150460
12.

Neuraminidase Inhibitors in Influenza Treatment and Prevention⁻Is It Time to Call It a Day?

Parra-Rojas C, Nguyen VK, Hernandez-Mejia G, Hernandez-Vargas EA.

Viruses. 2018 Aug 25;10(9). pii: E454. doi: 10.3390/v10090454.

13.

Development of a quadruple qRT-PCR assay for simultaneous identification of highly and low pathogenic H7N9 avian influenza viruses and characterization against oseltamivir resistance.

Yang Y, Li S, Wong G, Ma S, Xu Z, Zhao X, Li H, Xu W, Zheng H, Lin J, Zhao Q, Liu W, Liu Y, Gao GF, Bi Y.

BMC Infect Dis. 2018 Aug 15;18(1):406. doi: 10.1186/s12879-018-3302-7.

14.

Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.

Tivane A, Daniels R, Nguenha N, Machalele L, Nacoto A, Pale M, Mateonane E, Mavale S, Chilundo J, Muteto D, Salência J, Albati F, Gudo E, Mussá T, McCauley J.

PLoS One. 2018 Jul 26;13(7):e0201248. doi: 10.1371/journal.pone.0201248. eCollection 2018.

15.

PK/PD-based adaptive tailoring of oseltamivir doses to treat within-host influenza viral infections.

Montaseri G, Boianelli A, Hernandez-Vargas EA, Meyer-Hermann M.

Prog Biophys Mol Biol. 2018 Nov;139:31-42. doi: 10.1016/j.pbiomolbio.2018.07.007. Epub 2018 Jul 19.

PMID:
30031022
16.

[Analysis of 15 cases of avian influenza virus (H7N9) infection].

Yu WQ, Ding MD, Dai GH, Gu CJ, Xue L, Chen Y, Zhou DM, Xian JC, Xu HT.

Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jul 12;41(7):534-538. doi: 10.3760/cma.j.issn.1001-0939.2018.07.006. Chinese.

PMID:
29996349
17.

Outbreaks of influenza-like illness in care homes in the East of England: impact of variations in neuraminidase inhibitor provision.

Yip JLY, Kapadia S, Ahmed A, Millership S.

Public Health. 2018 Sep;162:98-103. doi: 10.1016/j.puhe.2018.05.028. Epub 2018 Jul 7.

18.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A.

Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3.

19.

When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature.

Hékimian G, Jovanovic T, Bréchot N, Lebreton G, Leprince P, Trouillet JL, Schmidt M, Nieszkowska A, Besset S, Chastre J, Combes A, Luyt CE.

J Crit Care. 2018 Oct;47:61-64. doi: 10.1016/j.jcrc.2018.06.001. Epub 2018 Jun 9.

PMID:
29929152
20.

Supplemental Content

Loading ...
Support Center